AQR Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.1M Buy
948,810
+467,474
+97% +$6.83M 0.01% 1185
2025
Q4
$7.68M Buy
481,336
+123,044
+34% +$1.74M ﹤0.01% 1335
2025
Q3
$3.96M Buy
358,292
+143,642
+67% +$1.57M ﹤0.01% 1588
2025
Q2
$1.82M Sell
214,650
-288,893
-57% -$2.32M ﹤0.01% 1837
2025
Q1
$4.05M Buy
503,543
+40,380
+9% +$327K ﹤0.01% 1234
2024
Q4
$4.16M Sell
463,163
-105,155
-19% -$858K 0.01% 1179
2024
Q3
$4.17M Buy
568,318
+366,077
+181% +$2.27M 0.01% 1142
2024
Q2
$1.15M Buy
+202,241
New +$1.07M ﹤0.01% 1686
2024
Q1
Sell
-21,435
Closed -$193K 2415
2023
Q4
$193K Buy
21,435
+2,829
+15% +$23.3K ﹤0.01% 2223
2023
Q3
$145K Buy
18,606
+7,446
+67% +$72.8K ﹤0.01% 2185
2023
Q2
$108K Sell
11,160
-12,454
-53% -$129K ﹤0.01% 2141
2023
Q1
$259K Buy
23,614
+11,658
+98% +$103K ﹤0.01% 1984
2022
Q4
$51.6K Buy
+11,956
New +$69.4K ﹤0.01% 2169

Other funds holding AUPH